Get started
Award

RHUS-0017

Funded outputs count: 24
Funder award ID: RHUS-0017
OpenAlex ID: G1912211089
STAT3 inhibition for the induction of immunogenic cell death in multiple myeloma
2026 · Oliver Kepp, Guido Kroemer · OncoImmunology
PDF
Glycometabolic, inflammatory and exocrine plasma proteins predict cancer in individuals with cardiovascular disease
2026 · Marine Fidelle, David Boulate, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
ACBP/DBI Neutralization Stimulates Anticancer Immune Responses by Upregulating Lamin A in T Cells
2026 · Sijing Li, Carlos López-Otín, et al. · ImmunoTargets and Therapy
Stress management by benzodiazepines in septic shock and critical illness: mechanistic and clinical evidence supporting alternative sedative strategies
2026 · Flavia Lambertucci, David Skurnik, et al. · Cell Stress
PDF
Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy
2026 · Anne-Laure Mallard de La Varende, Ai-Ling Tian, et al. · Cancer Cell · 3
PDF
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling
2026 · Déborah Suissa, Marine Fidelle, et al. · Nature Medicine · 7
PDF
Trial watch: antibody-drug conjugates in cancer therapy
2026 · Flora Doffe, Xiaolian Deng, et al. · OncoImmunology · 1
PDF
Pharmacological inhibition of MAPK P38α rescues the immune defect of dendritic cells affected by the FPR1 loss-of-function polymorphism rs867228
2026 · Liwei Zhao, Oliver Kepp, et al. · OncoImmunology
PDF
KRAS-elicited PDIA6 blocks PERK-dependent immunogenic cell death in pancreatic carcinoma
2026 · Liwei Zhao, Peng Liu, et al. · OncoImmunology
PDF
Gut dysbiosis in oncology: a risk factor for immunoresistance
2026 · Andrew Allan Almonte, Simon Thomas, et al. · Cell Research · 24
Increased plasma concentrations of acyl-coenzyme A binding protein (ACBP) predict future lung cancer development in smokers at risk of cardiovascular disease
2025 · Marine Fidelle, Hui Chen, et al. · Molecular Cancer · 4
PDF
FDA approves lurbinectedin in combination with atezolizumab for extensive-stage small cell lung cancer
2025 · Oliver Kepp, Guido Kroemer · OncoImmunology · 5
PDF
Disruption of cholesterol homeostasis by antidepressants induces immunogenic cell death
2025 · Karla Alvarez-Valadez, Jonathan G. Pol, et al. · OncoImmunology · 3
PDF
The interplay between gut microbiota, antibiotics, and immune checkpoint inhibitors in patients with cancer: A narrative review with biological and clinical aspects
2025 · Demi Wekking, Carolina Alves Costa Silva, et al. · Critical Reviews in Oncology/Hematology · 22
Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship
2025 · Arielle Elkrief, Bertrand Routy, et al. · American Society of Clinical Oncology Educational Book · 32
PDF
Surrogate markers of intestinal dysfunction associated with survival in advanced cancers
2025 · Roxanne Birebent, Damien Drubay, et al. · OncoImmunology · 21
PDF
Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritis
2025 · Uxía Nogueira-Recalde, Flavia Lambertucci, et al. · Cell Death and Differentiation · 10
Spermidine alleviates depression via control of the stress response
2024 · Sarah Mackert, Christine Niemeyer, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5
PDF
Neutralization of the autophagy-repressive tissue hormone DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein) enhances anticancer immunosurveillance
2024 · Léa Montégut, Isabelle Martins, et al. · Autophagy · 5
The autophagy-repressive tissue hormone DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein) suppresses anorexia
2024 · Hui Chen, Isabelle Martins, et al. · Autophagy · 6
PDF
A surge in endogenous spermidine is essential for rapamycin-induced autophagy and longevity
2024 · Sebastian J. Hofer, Ioanna Daskalaki, et al. · Autophagy · 25
PDF
Obesity-Associated Colorectal Cancer
2024 · Lucia Gonzalez-Gutierrez, Omar Motiño, et al. · International Journal of Molecular Sciences · 48
PDF
Targeted opening of the blood–brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma
2024 · Jonathan G. Pol, Manuela Lizarralde-Guerrero, et al. · OncoImmunology · 4
PDF
RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies
2023 · Camille Bigenwald, Yacine Haddad, et al. · OncoImmunology · 11
PDF
Year
Topic